1. Home
  2. TRMK vs BHVN Comparison

TRMK vs BHVN Comparison

Compare TRMK & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trustmark Corporation

TRMK

Trustmark Corporation

SELL

Current Price

$44.52

Market Cap

2.6B

Sector

Finance

ML Signal

SELL

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

HOLD

Current Price

$11.79

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRMK
BHVN
Founded
1889
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.1B
IPO Year
1994
2022

Fundamental Metrics

Financial Performance
Metric
TRMK
BHVN
Price
$44.52
$11.79
Analyst Decision
Hold
Buy
Analyst Count
6
17
Target Price
★ $50.50
$21.27
AVG Volume (30 Days)
351.1K
★ 2.4M
Earning Date
10-27-2026
11-05-2026
Dividend Yield
★ 2.26%
N/A
EPS Growth
1.93
★ 26.08
EPS
★ 2.03
N/A
Revenue
N/A
N/A
Revenue This Year
$5.36
N/A
Revenue Next Year
$6.20
N/A
P/E Ratio
$21.79
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$36.33
$7.48
52 Week High
$49.00
$18.57

Technical Indicators

Market Signals
Indicator
TRMK
BHVN
Relative Strength Index (RSI) 39.25 37.25
Support Level $43.37 $10.75
Resistance Level $45.48 $12.03
Average True Range (ATR) 0.72 0.68
MACD -0.12 -0.12
Stochastic Oscillator 23.42 9.02

Price Performance

Historical Comparison
TRMK
BHVN

About TRMK Trustmark Corporation

Trustmark Corp is a bank holding company. Through its subsidiaries, the company operates as a financial services organization providing banking and other financial solutions in Alabama, Florida, Mississippi, Tennessee, and Texas. Its principal products and services include Commercial Banking, Consumer Banking, Mortgage Banking, Insurance, Wealth Management and Trust Services, and others. The company is managed along two operating segments: General Banking and Wealth Management. The General Banking segment, which generates the majority of the revenue, provides all traditional banking products and services, including loan deposits, and also consists of internal operations.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.

Share on Social Networks: